Article
Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer.
Chest - 1 Jul 2005
Hsieh Ruey-Kuen, Lim Ken-Hong, Kuo Hsu-Tah, Tzen Chin-Yuan, Huang Ming-Jer
Abstract excerpt
STUDY OBJECTIVES: The prevalence of epidermal growth factor receptor (EGFR) mutations in gefitinib-naive lung cancer patients is higher in adenocarcinomas, in women, and in Japanese. To further investigate the prevalence of EGFR mutations in relation to ethnic and geographic factors, we evaluated EGFR mutations in a series of Taiwanese patients with primary lung adenocarcinomas who had never been treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
